← Back to Clinical Trials
Recruiting NCT07225894

PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pilot Phase

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition HIV
Sponsor Duke University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 160
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-12-01
Completion 2026-03-31
Interventions
Ethnodrama Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The investigators will pilot test an ethnodrama intervention designed to transform community member beliefs about and foster support of young cisgender women (YCW) using Pre-exposure Prophylaxis (PrEP).

Eligibility Criteria

Inclusion: * Young women who are currently using or have previously used PrEP * Community members (adult women and men) who will be identified from the audience during the first play in a round * Adult audience members (female and male) who heard about the play from the public announcements and chose to attend and watch the play Exclusion: * N/A

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE HIV TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}